Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery
暂无分享,去创建一个
S. Lee | H. Kim | T. Kim | S. Kim | Haeyoung Jeong | Jae Jong Kim | H. Choy | K. Yi | J. Rhee
[1] T. Shiota,et al. The enzymatic synthesis of hydroxymethyldihydropteridine pyrophosphate and dihydrofolate. , 1969, Biochemistry.
[2] R. Colwell,et al. Extractable Lipids of Gram-Negative Marine Bacteria: Phospholipid Composition , 1973 .
[3] R. Colwell,et al. Extractable Lipids of Gram-Negative Marine Bacteria: Phospholipid Composition , 1973, Journal of bacteriology.
[4] R. Moellering,et al. Management of infections caused by gram-negative bacilli: the role of antimicrobial combinations. , 1985, Reviews of infectious diseases.
[5] G. Wisse,et al. Variation in Quantitative Requirements for Na+ for Transport of Metabolizable Compounds by the Marine Bacteria Alteromonas haloplanktis 214 and Vibrio fischeri , 1987, Applied and environmental microbiology.
[6] J. Mekalanos,et al. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR , 1988, Journal of bacteriology.
[7] K. Hisatsune,et al. [Chemical properties of lipopolysaccharide (LPS) isolated from Vibrio anguillarum PT514]. , 1989, Nihon saikingaku zasshi. Japanese journal of bacteriology.
[8] S. Ho,et al. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. , 1989, Gene.
[9] H. Shon,et al. Vibrio vulnificus septicemia in Korea: clinical and epidemiologic findings in seventy patients. , 1991, Journal of the American Academy of Dermatology.
[10] D. Milton,et al. Flagellin A is essential for the virulence of Vibrio anguillarum , 1996, Journal of bacteriology.
[11] K. Klontz,et al. The epidemiology of Vibrio infections in Florida, 1981-1993. , 1996, The Journal of infectious diseases.
[12] S. Radu,et al. Characterization of Vibrio vulnificus isolated from cockles (Anadara granosa): antimicrobial resistance, plasmid profiles and random amplification of polymorphic DNA analysis. , 1998, FEMS microbiology letters.
[13] Winfried Boos,et al. Maltose/Maltodextrin System of Escherichia coli: Transport, Metabolism, and Regulation , 1998, Microbiology and Molecular Biology Reviews.
[14] Mary Jane Ferraro,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .
[15] S. Salzberg,et al. DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae , 2000, Nature.
[16] F. Baquero,et al. Mutation Frequencies and Antibiotic Resistance , 2000, Antimicrobial Agents and Chemotherapy.
[17] R. Lütticken,et al. Discriminative power of fatty acid methyl ester (FAME) analysis using the microbial identification system (MIS) for Candida (Torulopsis) glabrata and Saccharomyces cerevisiae. , 2000, Diagnostic microbiology and infectious disease.
[18] W. Eisenreich,et al. The non-mevalonate pathway of isoprenoids: genes, enzymes and intermediates. , 2001, Current opinion in chemical biology.
[19] J. Mallion,et al. Should One Use Echocardiography or Contrast Transcranial Doppler Ultrasound for the Detection of a Patent Foramen Ovale after an Ischemic Cerebrovascular Accident? , 2001, Cerebrovascular Diseases.
[20] Enzyme-ligand complexes of pyridoxine 5'-phosphate synthase: implications for substrate binding and catalysis. , 2002, Journal of molecular biology.
[21] T. A. Brown,et al. Synthesis and Processing of RNA , 2002 .
[23] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[24] Owen White,et al. The TIGRFAMs database of protein families , 2003, Nucleic Acids Res..
[25] An-Ping Zeng,et al. The Connectivity Structure, Giant Strong Component and Centrality of Metabolic Networks , 2003, Bioinform..
[26] B. Palsson,et al. An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR) , 2003, Genome Biology.
[27] R. Levesque,et al. Structure and function of the Mur enzymes: development of novel inhibitors , 2002, Molecular microbiology.
[28] An-Ping Zeng,et al. Reconstruction of metabolic networks from genome data and analysis of their global structure for various organisms , 2003, Bioinform..
[29] Masahira Hattori,et al. Genome sequence of Vibrio parahaemolyticus: a pathogenic mechanism distinct from that of V cholerae , 2003, The Lancet.
[30] Sang Yup Lee,et al. MetaFluxNet: the management of metabolic reaction information and quantitative metabolic flux analysis , 2003, Bioinform..
[31] G. Scapin,et al. The three-dimensional structures of the Mycobacterium tuberculosis dihydrodipicolinate reductase-NADH-2,6-PDC and -NADPH-2,6-PDC complexes. Structural and mutagenic analysis of relaxed nucleotide specificity. , 2003, Biochemistry.
[32] Darren A. Natale,et al. The COG database: an updated version includes eukaryotes , 2003, BMC Bioinformatics.
[33] Matthew K. Waldor,et al. Distinct Replication Requirements for the Two Vibrio cholerae Chromosomes , 2003, Cell.
[34] C. Walsh. Opinion — anti-infectives: Where will new antibiotics come from? , 2003, Nature Reviews Microbiology.
[35] Young Ran Kim,et al. Characterization and Pathogenic Significance of Vibrio vulnificus Antigens Preferentially Expressed in Septicemic Patients , 2003, Infection and Immunity.
[36] Yuantao Liu,et al. Novel Concentration-Killing Curve Method for Estimation of Bactericidal Potency of Antibiotics in an In Vitro Dynamic Model , 2004, Antimicrobial Agents and Chemotherapy.
[37] Christoph Freiberg,et al. The impact of transcriptome and proteome analyses on antibiotic drug discovery. , 2004, Current opinion in microbiology.
[38] E. Greenberg,et al. Complete genome sequence of Vibrio fischeri: a symbiotic bacterium with pathogenic congeners. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[39] C. Ho,et al. Identification and Characterization of the Vibrio vulnificus malPQ Operon , 2005 .
[40] Young Ran Kim,et al. Essential role of an adenylate cyclase in regulating Vibrio vulnificus virulence. , 2005, FEMS microbiology letters.
[41] B. Palsson,et al. Expanded Metabolic Reconstruction of Helicobacter pylori (iIT341 GSM/GPR): an In Silico Genome-Scale Characterization of Single- and Double-Deletion Mutants , 2005, Journal of bacteriology.
[42] R. Fernley,et al. Purification, properties, and crystallization of Saccharomyces cerevisiae dihydropterin pyrophosphokinase-dihydropteroate synthase. , 2005, Protein expression and purification.
[43] P. Gulig,et al. Molecular Pathogenesis of Vibrio vulnificus. , 2005, Journal of microbiology.
[44] Ian T. Paulsen,et al. Comparative Analyses of Fundamental Differences in Membrane Transport Capabilities in Prokaryotes and Eukaryotes , 2005, PLoS Comput. Biol..
[45] S. Choi,et al. Identification of the Vibrio vulnificus wbpP Gene and Evaluation of Its Role in Virulence , 2006, Infection and Immunity.
[46] Marcus J. Claesson,et al. Genomic island identification in Vibrio vulnificus reveals significant genome plasticity in this human pathogen , 2006, Bioinform..
[47] Clinical,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : Approved standard , 2006 .
[48] Kiyoko F. Aoki-Kinoshita,et al. From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..
[49] S. D. Mills. When will the genomics investment pay off for antibacterial discovery? , 2006, Biochemical pharmacology.
[50] H. Mori,et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection , 2006, Molecular systems biology.
[51] M. Perugini,et al. Inhibition of lysine biosynthesis: an evolving antibiotic strategy. , 2007, Molecular bioSystems.
[52] D. Blanot,et al. Phosphinate Inhibitors of UDP‐N‐Acetylmuramoyl‐L‐Alanyl‐D‐Glutamate: L‐Lysine Ligase (MurE) , 2007, Archiv der Pharmazie.
[53] T. Lundqvist,et al. Exploitation of structural and regulatory diversity in glutamate racemases , 2007, Nature.
[54] Michael L. Creech,et al. Integration of biological networks and gene expression data using Cytoscape , 2007, Nature Protocols.
[55] Sang Yup Lee,et al. Metabolite essentiality elucidates robustness of Escherichia coli metabolism , 2007, Proceedings of the National Academy of Sciences.
[56] Refined Medium for Direct Isolation of Vibrio vulnificus from Oyster Tissue and Seawater , 2007, Applied and Environmental Microbiology.
[57] M. H. Bross,et al. Vibrio vulnificus infection: diagnosis and treatment. , 2007, American family physician.
[58] Jeong Wook Lee,et al. Construction and Characterization of Shuttle Vectors for Succinic Acid-Producing Rumen Bacteria , 2007, Applied and Environmental Microbiology.
[59] L. Silver. Multi-targeting by monotherapeutic antibacterials , 2007, Nature Reviews Drug Discovery.
[60] D. Pompliano,et al. Drugs for bad bugs: confronting the challenges of antibacterial discovery , 2007, Nature Reviews Drug Discovery.
[61] Rick L. Stevens,et al. The RAST Server: Rapid Annotations using Subsystems Technology , 2008, BMC Genomics.
[62] Yue Li,et al. Structure and activity of Yersinia pestis 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase as a novel target for the development of antiplague therapeutics. , 2007, Acta crystallographica. Section D, Biological crystallography.
[63] Bernhard O. Palsson,et al. Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets , 2007 .
[64] The pyrH Gene of Vibrio vulnificus Is an Essential In Vivo Survival Factor , 2007, Infection and Immunity.
[65] Jong Myoung Park,et al. Genome-scale analysis of Mannheimia succiniciproducens metabolism. , 2007, Biotechnology and bioengineering.
[66] Monica L. Mo,et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.
[67] Roger Guimerà,et al. A network-based method for target selection in metabolic networks , 2007, Bioinform..
[68] 박순정. Role of NtrC in biofilm formation via controlling expression of the gene encoding an ADP-glycero-manno-heptose-6-epimerase in the pathogenic bacterium, Vibrio vulnificus , 2007 .
[69] H. Kitano. A robustness-based approach to systems-oriented drug design , 2007, Nature Reviews Drug Discovery.
[70] Kyu-Ho Lee,et al. Role of NtrC in biofilm formation via controlling expression of the gene encoding an ADP‐glycero‐manno‐heptose‐6‐epimerase in the pathogenic bacterium, Vibrio vulnificus , 2007, Molecular microbiology.
[71] P. Cook,et al. Examination of intrinsic sulfonamide resistance in Bacillus anthracis: a novel assay for dihydropteroate synthase. , 2008, Biochimica et biophysica acta.
[72] R. Stepanauskas,et al. Multi-site Analysis Reveals Widespread Antibiotic Resistance in the Marine Pathogen Vibrio vulnificus , 2008, Microbial Ecology.
[73] Jason A. Papin,et al. Genome-scale Metabolic Network Analysis of the Opportunistic Pathogen Pseudomonas Aeruginosa Pao1 , 2022 .
[74] J. Derrick. The structure and mechanism of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase. , 2008, Vitamins and hormones.
[75] P. Niyomrattanakit,et al. Biochemical and structural characterization of the putative dihydropteroate synthase ortholog Rv1207 of Mycobacterium tuberculosis. , 2008, FEMS microbiology letters.
[76] S. Lee,et al. Metabolic flux analysis and metabolic engineering of microorganisms. , 2008, Molecular bioSystems.
[77] Fidel Ramírez,et al. Computing topological parameters of biological networks , 2008, Bioinform..
[78] H. Ackermann,et al. Synergistic Antimicrobial Activities of Folic Acid Antagonists and Nucleoside Analogs , 2009, Antimicrobial Agents and Chemotherapy.
[79] J. Oliver,et al. Vibrio vulnificus: Disease and Pathogenesis , 2009, Infection and Immunity.
[80] C. Médigue,et al. Genome sequence of Vibrio splendidus: an abundant planctonic marine species with a large genotypic diversity. , 2009, Environmental microbiology.
[81] M. Rybak,et al. In Vitro Activity of Ceftaroline against Methicillin-Resistant Staphylococcus aureus and Heterogeneous Vancomycin-Intermediate S. aureus in a Hollow Fiber Model , 2009, Antimicrobial Agents and Chemotherapy.
[82] D. Kell,et al. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries. , 2009, Drug discovery today.
[83] Christopher T. Walsh,et al. Antibiotics for Emerging Pathogens , 2009, Science.
[84] A. Barabasi,et al. Targets Drug Genomes Identify Novel Antimicrobial Staphylococcus Aureus of Multiple Reconstruction and Flux Balance Analysis Comparative Genome-scale Metabolic Supplemental Material , 2009 .
[85] Jong Myoung Park,et al. Constraints-based genome-scale metabolic simulation for systems metabolic engineering. , 2009, Biotechnology advances.
[86] Salomon Amar,et al. Metabolic Network Model of a Human Oral Pathogen , 2008, Journal of bacteriology.
[87] B. Palsson,et al. A protocol for generating a high-quality genome-scale metabolic reconstruction , 2010 .
[88] A. Barabasi,et al. Blueprint for antimicrobial hit discovery targeting metabolic networks , 2010, Proceedings of the National Academy of Sciences.
[89] S. Lee,et al. Genome-scale metabolic network analysis and drug targeting of multi-drug resistant pathogen Acinetobacter baumannii AYE. , 2010, Molecular bioSystems.
[90] Hyun Uk Kim,et al. Metabolite-centric approaches for the discovery of antibacterials using genome-scale metabolic networks. , 2010, Metabolic engineering.